Beyond COVID-19: The New Normal in Risk Based Monitoring and Quality Management


Register Now

Please join this webinar to learn first-hand how the Parexel and CluePoints partnership is driving best in class Risk-Based Quality Management strategies to support clinical development. This session will focus on how early risk detection can be leveraged to detect issues across your trial and ensure operational excellence. As the COVID-19 pandemic continues, actions need to be prioritized to combat the disruption to in-flight trials. We believe the challenge of identifying and actioning these critical issues in a timely manner will be the catalyst in driving the adoption of central / remote monitoring going forward. We will share best practices for today and future.

Key areas of insights:

• Enhanced data quality oversight and regulatory compliance

• Proactive risk management to protect patient safety

• Driving the quality, accuracy, and integrity of clinical trial data

• Increased productivity, efficiency and cost effectiveness for sponsors


Sponsored by: Parexel

Nick May, Sr. Director Risk Based Monitoring, Parexel
Steve Young, Chief Scientific Officer, CluePoints